Sangamo Therapeutics, Inc. SGMOQ
0.14
(0.01)
(6.67%)
as of 25 Sep
- Market cap
- $41.9M
- P/E
- 0.0×
Follow SGMOQ
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
11.28 | 37.48 | 13.18 | 9.16 | 17.76 | 9.79 | 4.35 | 0.55 | 3.56 | 2.98 |
P/FCF ratio |
0.00 | 184.49 | 0.00 | 0.00 | 13.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(18.59) | (81.37) | (27.71) | (45.08) | (488.65) | (20.57) | (8.50) | (1.93) | (61.39) | (4.82) |
P/B ratio |
1.61 | 7.29 | 3.03 | 2.17 | 4.22 | 2.89 | 1.64 | 1.18 | 9.04 | 0.00 |
Price to Tangible BV |
1.62 | 7.36 | 4.08 | 2.76 | 5.29 | 3.85 | 2.34 | 3.12 | 0.00 | 0.00 |
EV/Sales |
4.13 | 31.50 | 8.77 | 6.02 | 12.66 | 6.79 | 2.21 | 0.29 | 3.44 | 3.33 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.22) | 103.03 | 20.26 | (4.27) | 8.80 | (3.22) | (1.10) | (0.23) | (2.96) | (1.35) |
EV/FCF |
(1.20) | 155.06 | (113.65) | (3.74) | 9.64 | (2.93) | (1.01) | (0.21) | (2.73) | (1.34) |
Quick Ratio |
11.12 | 5.50 | 5.16 | 5.73 | 4.51 | 2.99 | 2.53 | 1.72 | 0.93 | 0.50 |
Current Ratio |
11.25 | 5.54 | 5.23 | 5.80 | 4.60 | 3.12 | 2.69 | 1.98 | 1.13 | 0.84 |
Net Debt/EBITDA |
1.94 | 3.94 | 4.62 | 3.20 | 5.15 | 2.04 | 1.31 | 0.49 | 0.44 | 0.18 |
Debt/Assets |
2.50% | 8.63% | 4.69% | 6.46% | 4.09% | 6.10% | 6.93% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.03 | 0.13 | 0.08 | 0.10 | 0.08 | 0.12 | 0.13 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.10 | 0.16 | 0.19 | 0.17 | 0.15 | 0.13 | 0.17 | 0.48 | 0.43 | 0.49 |
Operating CF/Net income |
0.92 | (0.20) | (0.53) | 1.52 | (1.40) | 1.31 | 1.16 | 0.87 | 0.69 | 0.79 |
Capex/Depreciation |
(0.60) | (4.55) | 12.41 | (4.22) | (1.17) | (1.14) | (1.04) | (0.19) | (0.03) | (0.01) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (43.61%) | (33.67%) | (24.62%) | (23.80%) | (26.02%) | (40.86%) | (57.37%) | (136.47%) | (185.39%) | (2,891.84%) | |
| (38.20%) | (24.55%) | (15.58%) | (15.50%) | (15.35%) | (21.47%) | (29.94%) | (70.85%) | (73.38%) | (152.35%) | |
ROIC |
0.00% | 0.00% | 0.00% | (58.98%) | 0.00% | (267.41%) | (223.40%) | (9,085.05%) | 0.00% | 0.00% |
Return on Tangible Assets |
(50.16%) | (23.26%) | (16.64%) | (26.04%) | (21.71%) | (55.30%) | (76.26%) | (350.93%) | (411.98%) | (2,790.10%) |
Average Days of Receivables |
97.82 | 35.76 | 21.82 | 133.95 | 19.33 | 20.98 | 14.67 | 1.91 | 3.32 | 3.42 |
Research and Development Expense of Revenue |
338.43% | 179.75% | 136.01% | 142.46% | 152.84% | 208.51% | 224.53% | 132.81% | 192.94% | 284.87% |
Selling, General and Administrative Expense of Revenue |
135.80% | 74.38% | 55.34% | 60.22% | 56.77% | 57.11% | 56.32% | 34.71% | 77.38% | 88.20% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.16 | 0.15 | 0.11 | 0.13 | 0.16 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
77.66% | 24.86% | 17.38% | 18.87% | 21.75% | 29.77% | 28.44% | 15.53% | 21.42% | 22.95% |
Graham Net Nets |
0.58 | 0.11 | 0.17 | 0.21 | 0.10 | 0.05 | 0.07 | 0.12 | (0.13) | (0.32) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 |
Earnings Yield |
(32.90%) | (3.99%) | (6.18%) | (10.39%) | (5.96%) | (16.53%) | (39.81%) | (260.71%) | (50.00%) | (104.76%) |
Free Cash Flow Yield |
(30.46%) | 0.54% | (0.59%) | (17.59%) | 7.39% | (23.66%) | (50.30%) | (251.82%) | (35.40%) | (83.22%) |
Revenue per Share |
0.27 | 0.47 | 0.87 | 0.91 | 0.88 | 0.77 | 0.72 | 1.01 | 0.29 | 0.14 |
Operating CF per Share |
(0.93) | 0.14 | 0.38 | (1.29) | 1.26 | (1.61) | (1.45) | (1.29) | (0.33) | (0.35) |
Capex per Share |
(0.01) | (0.05) | (0.44) | (0.18) | (0.11) | (0.16) | (0.13) | (0.12) | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.94) | 0.10 | (0.07) | (1.47) | 1.15 | (1.77) | (1.58) | (1.41) | (0.33) | (0.35) |
Cash per Share |
2.02 | 3.12 | 4.13 | 3.23 | 4.77 | 2.60 | 1.80 | 0.46 | 0.21 | 0.07 |
Shareholders Equity per Share |
1.93 | 2.41 | 3.79 | 3.86 | 3.70 | 2.60 | 1.91 | 0.48 | 0.11 | (0.05) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.93 | 2.41 | 3.79 | 3.86 | 3.70 | 2.60 | 1.91 | 0.48 | 0.11 | (0.05) |
Free Cash Flow |
(66.61) | 7.43 | (6.51) | (165.08) | 155.16 | (256.53) | (243.80) | (246.00) | (67.41) | (97.31) |
Working Capital |
136.29 | 203.54 | 332.01 | 335.60 | 516.12 | 270.88 | 188.62 | 46.60 | 5.89 | (6.64) |
Capital Expenditures |
(0.73) | (3.75) | (43.06) | (20.67) | (14.71) | (23.28) | (20.17) | (21.15) | (0.27) | (0.10) |
Net Current Asset Value |
127.88 | 149.56 | 187.38 | 200.70 | 218.48 | 52.19 | 32.78 | 11.90 | (27.17) | (38.18) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.04 | 0.10 | 0.51 | 0.20 | 0.12 | 0.21 | 0.18 | 0.12 | 0.00 | 0.00 |
Net Profit Margin |
(369.58%) | (149.23%) | (80.91%) | (92.93%) | (102.37%) | (161.05%) | (172.76%) | (146.30%) | (169.45%) | (310.81%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.19 | 0.03 | (0.04) | 0.16 | 0.30 | 0.40 | 0.30 | 4.07 | 0.52 | 0.69 |
Cash ROIC |
(25.63%) | (4.36%) | (5.30%) | (20.84%) | 10.92% | (35.78%) | (46.95%) | (153.59%) | (131.44%) | (1,620.51%) |
Accounts Receivable Turnover |
4.83 | 8.33 | 19.57 | 4.80 | 5.39 | 17.54 | 20.55 | 65.33 | 79.78 | 88.19 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 0.00 | 0.00 | — | — | — |
Average Receivables |
4.01 | 4.39 | 4.32 | 21.32 | 21.93 | 6.31 | 5.42 | 2.70 | 0.72 | 0.45 |
Average Payables |
7.25 | 8.65 | 16.25 | 14.06 | 9.61 | 11.16 | 16.09 | 18.84 | 15.37 | 14.96 |
Average Assets |
187.56 | 222.32 | 438.57 | 613.96 | 788.03 | 830.24 | 642.22 | 363.91 | 133.48 | 80.69 |
Average Common Equity |
164.32 | 162.05 | 277.58 | 400.00 | 465.05 | 436.35 | 335.15 | 188.92 | 52.83 | 4.25 |
Columns are period end dates